Pathomorphologic findings in left ventricular hypertrabeculation/noncompaction of adults in relation to neuromuscular

Daniel Gerger1, Claudia Stöllberger, Martin Grassberger

  • 1Krankenanstalt Rudolfstiftung, Juchgasse 25, A-1030 Wien, Austria.

Insights

Pathomorphologic assessment of left ventricular hypertrabeculation/noncompaction (LVHT) requires formaldehyde fixation and both long- and short-axis cardiac cuts. Subendocardial fibrosis is a consistent finding in LVHT.

Area of Science:

  • Cardiology
  • Pathology
  • Medical Imaging

Background:

  • Left ventricular hypertrabeculation/noncompaction (LVHT) is a congenital cardiomyopathy.
  • Echocardiography (ECHO) is commonly used for LVHT diagnosis.

Purpose of the Study:

  • To correlate echocardiographic (ECHO) findings with pathomorphologic (PATHO) features of LVHT.
  • To evaluate optimal methods for pathomorphologic assessment of LVHT.

Main Methods:

  • Echocardiographic criteria for LVHT included >3 trabeculations, synchronous movement, and a two-layered myocardium.
  • Autopsy hearts were examined fresh or formaldehyde-fixed, with long-axis and short-axis cuts.
  • Pathologists' preferences guided specimen investigation.

Main Results:

  • Twelve patients with LVHT were studied; 7 had neuromuscular disorders.
  • Formaldehyde fixation improved visualization of trabecular meshwork.
  • Long-axis cuts aided differentiation from papillary muscles; short-axis cuts revealed the two-layered structure.
  • Subendocardial fibrosis was present in all cases; trabeculation counting was impossible due to complex geometry.

Conclusions:

  • Formaldehyde fixation is recommended for comparing ECHO and PATHO findings in LVHT.
  • Both long- and short-axis cuts are essential for assessing trabeculations and myocardial structure.
  • Subendocardial fibrosis in LVHT warrants further investigation.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
565
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.3K
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
1.1K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
837
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.2K